A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination.
Malvi SG, Esmy PO, Muwonge R, Joshi S, Poli URR, Lucas E, Verma Y, Lucksom PG, Shah A, Patel B, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Divate U, Vashist S, Mishra G, Jadhav R, Siddiqi M, Sauvaget C, Sankaran S, Kannan TPRA, Shastri SS, Pillai MR, Anantharaman D, Bhatla N, Sankaranarayanan R, Basu P.
Malvi SG, et al. Among authors: jadhav r.
J Natl Cancer Inst Monogr. 2024 Nov 1;2024(67):317-328. doi: 10.1093/jncimonographs/lgae042.
J Natl Cancer Inst Monogr. 2024.
PMID: 39529521
Free PMC article.
Clinical Trial.